KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovoCure (NVCR) Equity Ratio (2016 - 2025)

Historic Equity Ratio for NovoCure (NVCR) over the last 12 years, with Q3 2025 value amounting to 0.25.

  • NovoCure's Equity Ratio fell 1506.61% to 0.25 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25, marking a year-over-year decrease of 1506.61%. This contributed to the annual value of 0.29 for FY2024, which is 821.91% down from last year.
  • NovoCure's Equity Ratio amounted to 0.25 in Q3 2025, which was down 1506.61% from 0.28 recorded in Q2 2025.
  • NovoCure's 5-year Equity Ratio high stood at 0.38 for Q2 2022, and its period low was 0.25 during Q3 2025.
  • Its 5-year average for Equity Ratio is 0.33, with a median of 0.35 in 2021.
  • Per our database at Business Quant, NovoCure's Equity Ratio plummeted by 4823.16% in 2021 and then surged by 872.07% in 2022.
  • NovoCure's Equity Ratio (Quarter) stood at 0.36 in 2021, then grew by 2.77% to 0.37 in 2022, then decreased by 14.57% to 0.32 in 2023, then dropped by 8.22% to 0.29 in 2024, then decreased by 13.62% to 0.25 in 2025.
  • Its last three reported values are 0.25 in Q3 2025, 0.28 for Q2 2025, and 0.29 during Q1 2025.